abstract |
The present invention relates to compounds of general formula (V), which are optionally pharmaceutically acceptable salts, solvates, polymorphs, co-drugs, co-crystals, prodrugs, tautomers, racemates , enantiomers or diastereomers or mixtures thereof, It is used for treating, improving or preventing viral diseases. In addition, specific combination therapies are disclosed. |